ID   M565
AC   CVCL_F0B7
RX   PubMed=29440125;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: KrasG12D/wtPtenloxP/loxPCD95loxP/loxPAmhr2-Cre transgenic.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=29440125; DOI=10.15252/embr.201745336; PMCID=PMC5836092;
RA   Murmann, Andrea E.
RA   Gao, Quan Q.
RA   Putzbach, William E.
RA   Patel, Monal
RA   Bartom, Elizabeth Thomas
RA   Law, Calvin Y.
RA   Bridgeman, Bryan B.
RA   Chen, Si-Quan
RA   McMahon, Kaylin M.
RA   Thaxton, Colby Shad
RA   Peter, Marcus Ernst
RT   "Small interfering RNAs based on huntingtin trinucleotide repeats are
RT   highly toxic to cancer cells.";
RL   EMBO Rep. 19:e45336.1-e45336.15(2018).
//